IONS logo

Ionis Pharmaceuticals (IONS) EBITDA

annual EBITDA:

-$353.72M-$117.85M(-49.96%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual EBITDA is -$353.72 million, with the most recent change of -$117.85 million (-49.96%) on December 31, 2024.
  • During the last 3 years, IONS annual EBITDA has fallen by -$348.53 million (-6718.06%).
  • IONS annual EBITDA is now -196.33% below its all-time high of $367.20 million, reached on December 31, 2019.

Performance

IONS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

quarterly EBITDA:

-$120.00M-$39.50M(-49.07%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly EBITDA is -$120.00 million, with the most recent change of -$39.50 million (-49.07%) on March 31, 2025.
  • Over the past year, IONS quarterly EBITDA has dropped by -$3.48 million (-2.99%).
  • IONS quarterly EBITDA is now -152.02% below its all-time high of $230.70 million, reached on December 31, 2021.

Performance

IONS quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM EBITDA:

-$355.72M-$3.48M(-0.99%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS TTM EBITDA is -$355.72 million, with the most recent change of -$3.48 million (-0.99%) on March 31, 2025.
  • Over the past year, IONS TTM EBITDA has dropped by -$96.24 million (-37.09%).
  • IONS TTM EBITDA is now -196.87% below its all-time high of $367.20 million, reached on December 31, 2019.

Performance

IONS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

IONS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-50.0%-3.0%-37.1%
3 y3 years-6718.1%-105.7%-1910.6%
5 y5 years-196.3%-153.5%-295.1%

IONS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6718.1%at low-606.5%at low-1129.8%at low
5 y5-year-196.3%at low-152.0%at low-295.1%at low
alltimeall time-196.3%at low-152.0%at low-196.9%at low

IONS EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$120.00M(+49.1%)
-$355.72M(+1.0%)
Dec 2024
-$353.72M(+50.0%)
-$80.50M(-31.4%)
-$352.23M(+42.0%)
Sep 2024
-
-$117.38M(+210.2%)
-$248.03M(+1.0%)
Jun 2024
-
-$37.84M(-67.5%)
-$245.50M(-5.4%)
Mar 2024
-
-$116.52M(-591.8%)
-$259.48M(+10.7%)
Dec 2023
-$235.87M(+3.6%)
$23.69M(-120.6%)
-$234.47M(-19.1%)
Sep 2023
-
-$114.84M(+121.6%)
-$289.74M(+34.3%)
Jun 2023
-
-$51.81M(-43.4%)
-$215.72M(-17.3%)
Mar 2023
-
-$91.51M(+189.8%)
-$260.90M(+14.6%)
Dec 2022
-$227.76M(+4290.1%)
-$31.58M(-22.6%)
-$227.74M(-759.3%)
Sep 2022
-
-$40.81M(-57.9%)
$34.54M(-1329.7%)
Jun 2022
-
-$96.99M(+66.2%)
-$2.81M(-114.3%)
Mar 2022
-
-$58.35M(-125.3%)
$19.65M(-464.9%)
Dec 2021
-$5.19M(-95.3%)
$230.70M(-395.1%)
-$5.38M(-97.8%)
Sep 2021
-
-$78.17M(+4.9%)
-$246.97M(+27.7%)
Jun 2021
-
-$74.53M(-10.6%)
-$193.47M(+30.8%)
Mar 2021
-
-$83.38M(+666.1%)
-$147.94M(+32.2%)
Dec 2020
-$111.19M(-130.3%)
-$10.88M(-55.9%)
-$111.90M(-201.4%)
Sep 2020
-
-$24.67M(-14.9%)
$110.36M(-28.4%)
Jun 2020
-
-$29.00M(-38.7%)
$154.22M(-15.4%)
Mar 2020
-
-$47.34M(-122.4%)
$182.31M(-50.4%)
Dec 2019
$367.20M(-2049.1%)
$211.37M(+1000.9%)
$367.20M(+102.2%)
Sep 2019
-
$19.20M(-2187.0%)
$181.57M(+15.7%)
Jun 2019
-
-$920.00K(-100.7%)
$157.00M(+35.6%)
Mar 2019
-
$137.55M(+434.3%)
$115.77M(-714.6%)
Dec 2018
-$18.84M(-151.8%)
$25.75M(-578.7%)
-$18.84M(-61.7%)
Sep 2018
-
-$5.38M(-87.2%)
-$49.13M(+33.2%)
Jun 2018
-
-$42.15M(-1530.3%)
-$36.90M(-322.5%)
Mar 2018
-
$2.95M(-164.8%)
$16.59M(-54.4%)
Dec 2017
$36.34M(-477.0%)
-$4.55M(-166.4%)
$36.34M(-66.4%)
Sep 2017
-
$6.86M(-39.5%)
$108.05M(-10.4%)
Jun 2017
-
$11.33M(-50.1%)
$120.56M(+88.3%)
Mar 2017
-
$22.70M(-66.2%)
$64.04M(-764.4%)
Dec 2016
-$9.64M(-76.5%)
$67.16M(+246.7%)
-$9.64M(-92.9%)
Sep 2016
-
$19.37M(-142.9%)
-$135.88M(-24.2%)
Jun 2016
-
-$45.19M(-11.4%)
-$179.17M(+108.9%)
Mar 2016
-
-$50.98M(-13.7%)
-$85.78M(+109.5%)
Dec 2015
-$40.94M(+79.7%)
-$59.08M(+146.9%)
-$40.94M(-194.2%)
Sep 2015
-
-$23.93M(-149.6%)
$43.45M(-12.2%)
Jun 2015
-
$48.20M(-886.0%)
$49.52M(-2010.5%)
Mar 2015
-
-$6.13M(-124.2%)
-$2.59M(-88.6%)
Dec 2014
-$22.78M(-39.1%)
$25.31M(-241.7%)
-$22.78M(-64.7%)
Sep 2014
-
-$17.86M(+356.9%)
-$64.59M(-6.7%)
Jun 2014
-
-$3.91M(-85.1%)
-$69.22M(-0.2%)
Mar 2014
-
-$26.32M(+59.5%)
-$69.36M(+85.3%)
Dec 2013
-$37.42M(-12.3%)
-$16.50M(-26.6%)
-$37.42M(+37.9%)
Sep 2013
-
-$22.49M(+455.3%)
-$27.14M(-26.8%)
Jun 2013
-
-$4.05M(-172.1%)
-$37.06M(+27.8%)
Mar 2013
-
$5.62M(-190.3%)
-$29.00M(-45.7%)
Dec 2012
-$42.68M(-24.2%)
-$6.22M(-80.8%)
-$53.44M(-14.0%)
Sep 2012
-
-$32.41M(-907.8%)
-$62.14M(+19.9%)
Jun 2012
-
$4.01M(-121.3%)
-$51.84M(-26.3%)
Mar 2012
-
-$18.81M(+26.0%)
-$70.29M(+3.3%)
Dec 2011
-$56.27M(+45.2%)
-$14.93M(-32.5%)
-$68.06M(+7.0%)
Sep 2011
-
-$22.11M(+53.1%)
-$63.63M(+25.7%)
Jun 2011
-
-$14.44M(-12.9%)
-$50.63M(-12.8%)
Mar 2011
-
-$16.58M(+57.9%)
-$58.08M(+21.2%)
Dec 2010
-$38.75M(+295.8%)
-$10.50M(+15.2%)
-$47.93M(-1.6%)
Sep 2010
-
-$9.12M(-58.4%)
-$48.69M(+0.6%)
Jun 2010
-
-$21.89M(+240.9%)
-$48.42M(+78.9%)
Mar 2010
-
-$6.42M(-43.0%)
-$27.06M(+41.7%)
Dec 2009
-$9.79M(-338.2%)
-$11.26M(+27.4%)
-$19.09M(+33.0%)
Sep 2009
-
-$8.84M(+1546.7%)
-$14.36M(+667.8%)
Jun 2009
-
-$537.00K(-134.6%)
-$1.87M(-191.2%)
Mar 2009
-
$1.55M(-123.7%)
$2.05M(-175.8%)
Dec 2008
$4.11M(-115.7%)
-$6.53M(-279.1%)
-$2.71M(-292.3%)
Sep 2008
-
$3.64M(+7.7%)
$1.41M(-82.0%)
Jun 2008
-
$3.38M(-205.5%)
$7.82M(-151.4%)
Mar 2008
-
-$3.21M(+32.8%)
-$15.22M(-53.8%)
Dec 2007
-$26.15M
-$2.41M(-124.0%)
-$32.92M(-25.9%)
DateAnnualQuarterlyTTM
Sep 2007
-
$10.06M(-151.2%)
-$44.42M(-39.2%)
Jun 2007
-
-$19.66M(-5.9%)
-$73.02M(+3.3%)
Mar 2007
-
-$20.90M(+50.2%)
-$70.68M(+7.5%)
Dec 2006
-$58.54M(+46.9%)
-$13.91M(-25.0%)
-$65.75M(+8.0%)
Sep 2006
-
-$18.54M(+7.1%)
-$60.87M(+11.0%)
Jun 2006
-
-$17.32M(+8.4%)
-$54.82M(+10.1%)
Mar 2006
-
-$15.98M(+76.9%)
-$49.78M(-0.9%)
Dec 2005
-$39.84M(-45.6%)
-$9.03M(-27.7%)
-$50.22M(-17.1%)
Sep 2005
-
-$12.49M(+1.8%)
-$60.56M(-14.0%)
Jun 2005
-
-$12.27M(-25.3%)
-$70.45M(-11.4%)
Mar 2005
-
-$16.42M(-15.2%)
-$79.51M(-6.9%)
Dec 2004
-$73.26M(+12.8%)
-$19.37M(-13.4%)
-$85.43M(-2.4%)
Sep 2004
-
-$22.38M(+4.9%)
-$87.53M(+3.9%)
Jun 2004
-
-$21.34M(-4.5%)
-$84.22M(+4.5%)
Mar 2004
-
-$22.34M(+4.0%)
-$80.60M(+4.4%)
Dec 2003
-$64.92M(+62.2%)
-$21.48M(+12.7%)
-$77.18M(+17.7%)
Sep 2003
-
-$19.07M(+7.6%)
-$65.57M(+2.4%)
Jun 2003
-
-$17.72M(-6.3%)
-$64.01M(+9.2%)
Mar 2003
-
-$18.91M(+91.6%)
-$58.63M(+18.6%)
Dec 2002
-$40.02M(+2.3%)
-$9.87M(-43.6%)
-$49.44M(+4.6%)
Sep 2002
-
-$17.51M(+41.9%)
-$47.26M(+37.1%)
Jun 2002
-
-$12.34M(+27.0%)
-$34.46M(-10.7%)
Mar 2002
-
-$9.72M(+26.3%)
-$38.59M(-16.3%)
Dec 2001
-$39.13M(+66.9%)
-$7.70M(+63.5%)
-$46.10M(-4.8%)
Sep 2001
-
-$4.71M(-71.4%)
-$48.42M(+11.3%)
Jun 2001
-
-$16.46M(-4.5%)
-$43.50M(+23.5%)
Mar 2001
-
-$17.23M(+72.1%)
-$35.22M(+21.5%)
Dec 2000
-$23.45M(-38.1%)
-$10.01M(-4960.2%)
-$28.99M(-7.9%)
Sep 2000
-
$206.00K(-102.5%)
-$31.48M(-20.9%)
Jun 2000
-
-$8.18M(-25.7%)
-$39.78M(-8.8%)
Mar 2000
-
-$11.01M(-11.9%)
-$43.61M(+1.2%)
Dec 1999
-$37.90M(+34.4%)
-$12.50M(+54.3%)
-$43.10M(+6.9%)
Sep 1999
-
-$8.10M(-32.5%)
-$40.30M(+29.6%)
Jun 1999
-
-$12.00M(+14.3%)
-$31.10M(-3.1%)
Mar 1999
-
-$10.50M(+8.2%)
-$32.10M(-1.5%)
Dec 1998
-$28.20M(+0.4%)
-$9.70M(-981.8%)
-$32.60M(-1.8%)
Sep 1998
-
$1.10M(-108.5%)
-$33.20M(-10.0%)
Jun 1998
-
-$13.00M(+18.2%)
-$36.90M(+9.8%)
Mar 1998
-
-$11.00M(+6.8%)
-$33.60M(+6.7%)
Dec 1997
-$28.10M(+6.0%)
-$10.30M(+296.2%)
-$31.50M(+2.6%)
Sep 1997
-
-$2.60M(-73.2%)
-$30.70M(-11.8%)
Jun 1997
-
-$9.70M(+9.0%)
-$34.80M(+4.8%)
Mar 1997
-
-$8.90M(-6.3%)
-$33.20M(+14.1%)
Dec 1996
-$26.50M(+16.2%)
-$9.50M(+41.8%)
-$29.10M(+12.8%)
Sep 1996
-
-$6.70M(-17.3%)
-$25.80M(-2.6%)
Jun 1996
-
-$8.10M(+68.8%)
-$26.50M(+8.6%)
Mar 1996
-
-$4.80M(-22.6%)
-$24.40M(-5.1%)
Dec 1995
-$22.80M(+22.6%)
-$6.20M(-16.2%)
-$25.70M(-16.3%)
Sep 1995
-
-$7.40M(+23.3%)
-$30.70M(+8.5%)
Jun 1995
-
-$6.00M(-1.6%)
-$28.30M(+4.4%)
Mar 1995
-
-$6.10M(-45.5%)
-$27.10M(+6.3%)
Dec 1994
-$18.60M(+23.2%)
-$11.20M(+124.0%)
-$25.50M(+36.4%)
Sep 1994
-
-$5.00M(+4.2%)
-$18.70M(+3.3%)
Jun 1994
-
-$4.80M(+6.7%)
-$18.10M(+1.1%)
Mar 1994
-
-$4.50M(+2.3%)
-$17.90M(-3.2%)
Dec 1993
-$15.10M(-23.0%)
-$4.40M(0.0%)
-$18.50M(-11.5%)
Sep 1993
-
-$4.40M(-4.3%)
-$20.90M(+0.5%)
Jun 1993
-
-$4.60M(-9.8%)
-$20.80M(+4.5%)
Mar 1993
-
-$5.10M(-25.0%)
-$19.90M(+2.1%)
Dec 1992
-$19.60M(+104.2%)
-$6.80M(+58.1%)
-$19.50M(+11.4%)
Sep 1992
-
-$4.30M(+16.2%)
-$17.50M(+15.1%)
Jun 1992
-
-$3.70M(-21.3%)
-$15.20M(+11.8%)
Mar 1992
-
-$4.70M(-2.1%)
-$13.60M(+34.7%)
Dec 1991
-$9.60M(+134.1%)
-$4.80M(+140.0%)
-$10.10M(-10.6%)
Sep 1991
-
-$2.00M(-4.8%)
-$11.30M(+28.4%)
Jun 1991
-
-$2.10M(+75.0%)
-$8.80M(+41.9%)
Mar 1991
-
-$1.20M(-80.0%)
-$6.20M(+37.8%)
Dec 1990
-$4.10M
-$6.00M(-1300.0%)
-$4.50M(-400.0%)
Sep 1990
-
$500.00K(0.0%)
$1.50M(+50.0%)
Jun 1990
-
$500.00K(0.0%)
$1.00M(+100.0%)
Mar 1990
-
$500.00K
$500.00K

FAQ

  • What is Ionis Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual EBITDA year-on-year change?
  • What is Ionis Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Ionis Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals TTM EBITDA year-on-year change?

What is Ionis Pharmaceuticals annual EBITDA?

The current annual EBITDA of IONS is -$353.72M

What is the all time high annual EBITDA for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual EBITDA is $367.20M

What is Ionis Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, IONS annual EBITDA has changed by -$117.85M (-49.96%)

What is Ionis Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of IONS is -$120.00M

What is the all time high quarterly EBITDA for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly EBITDA is $230.70M

What is Ionis Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, IONS quarterly EBITDA has changed by -$3.48M (-2.99%)

What is Ionis Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of IONS is -$355.72M

What is the all time high TTM EBITDA for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high TTM EBITDA is $367.20M

What is Ionis Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, IONS TTM EBITDA has changed by -$96.24M (-37.09%)
On this page